These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15195321)

  • 41. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. No effect of MMR withdrawal on the incidence of autism: a total population study.
    Honda H; Shimizu Y; Rutter M
    J Child Psychol Psychiatry; 2005 Jun; 46(6):572-9. PubMed ID: 15877763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An adult case of mumps brainstem meningoencephalitis with a past measles-mumps-rubella (MMR) vaccination.
    Hong JM; Jung KY
    Korean J Intern Med; 2006 Jun; 21(2):154-7. PubMed ID: 16913450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effectiveness of the mumps component of the MMR vaccine: a case control study.
    Harling R; White JM; Ramsay ME; Macsween KF; van den Bosch C
    Vaccine; 2005 Jul; 23(31):4070-4. PubMed ID: 15950329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren.
    Roost HP; Gassner M; Grize L; Wüthrich B; Sennhauser FH; Varonier HS; Zimmermann H; Braun-Fahrländer Ch;
    Pediatr Allergy Immunol; 2004 Oct; 15(5):401-7. PubMed ID: 15482514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No evidence of an association between MMR vaccine and gait disturbance.
    Miller E; Andrews N; Grant A; Stowe J; Taylor B
    Arch Dis Child; 2005 Mar; 90(3):292-6. PubMed ID: 15723921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study.
    Kulkarni PS; Phadke MA; Jadhav SS; Kapre SV
    Vaccine; 2005 Nov; 23(46-47):5286-8. PubMed ID: 15985315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
    Davidkin I; Jokinen S; Broman M; Leinikki P; Peltola H
    J Infect Dis; 2008 Apr; 197(7):950-6. PubMed ID: 18419470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mumps vaccine performance among university students during a mumps outbreak.
    Cortese MM; Jordan HT; Curns AT; Quinlan PA; Ens KA; Denning PM; Dayan GH
    Clin Infect Dis; 2008 Apr; 46(8):1172-80. PubMed ID: 18444852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is aseptic meningitis following mumps vaccination underreported in Japan?
    Uozumi Y; Miyahara M; Osaki K; Negoro M; Suga S
    Pediatr Int; 2022 Jan; 64(1):e14968. PubMed ID: 35189008
    [No Abstract]   [Full Text] [Related]  

  • 52. Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds.
    Cassidy WM; Jones G; Williams K; Deforest A; Forghani B; Virella G; Venters C
    J Adolesc Health; 2005 Mar; 36(3):187-92. PubMed ID: 15737773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The changing epidemiology of hospitalized pediatric patients in three measles outbreaks.
    Lee KY; Lee HS; Hur JK; Kang JH; Lee BC
    J Infect; 2007 Feb; 54(2):167-72. PubMed ID: 16620998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. No epidemiological evidence for infant vaccinations to cause allergic disease.
    Koppen S; de Groot R; Neijens HJ; Nagelkerke N; van Eden W; Rümke HC
    Vaccine; 2004 Sep; 22(25-26):3375-85. PubMed ID: 15308362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting.
    Jacobsen SJ; Ackerson BK; Sy LS; Tran TN; Jones TL; Yao JF; Xie F; Cheetham TC; Saddier P
    Vaccine; 2009 Jul; 27(34):4656-61. PubMed ID: 19520201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
    Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toward better vaccine safety data and safer vaccination.
    Braun MM
    Pediatrics; 2008 Mar; 121(3):625-6. PubMed ID: 18310214
    [No Abstract]   [Full Text] [Related]  

  • 58. [The relationship between MMR vaccination level and the number of new cases of autism in children].
    Mrozek-Budzyn D; Kiełtyka A
    Przegl Epidemiol; 2008; 62(3):597-604. PubMed ID: 19108524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying optimal risk windows for self-controlled case series studies of vaccine safety.
    Xu S; Zhang L; Nelson JC; Zeng C; Mullooly J; McClure D; Glanz J
    Stat Med; 2011 Mar; 30(7):742-52. PubMed ID: 21394750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mumps in a boarding school: description of an outbreak and control measures.
    Mackenzie DG; Craig G; Hallam NF; Moore J; Stevenson J
    Br J Gen Pract; 2006 Jul; 56(528):526-9. PubMed ID: 16834879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.